Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
Adabag
A Selcuk
AS
Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, MN 55417, USA. adaba001@umn.edu
Maron
Barry J
BJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D006801:Humans; D018570:Risk Assessment
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents